Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Perspective Therapeutics, Inc. Director's Dealing 2014

Jul 2, 2014

33510_dirs_2014-07-02_fa6c2e4a-4120-4302-8c4f-b090dd51ce3c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2014-05-27

Reporting Person: Cavanagh William (Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-05-27 Common Stock M 15000 $0.84 Acquired 15000 Direct
2014-05-27 Common Stock M 15571 $0.99 Acquired 30571 Direct
2014-05-27 Common Stock S 30571 $2.22 Disposed 0 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-05-27 Stock Options $0.84 M 15000 Disposed 2020-01-08 Common Stock (15000) Direct
2014-05-27 Stock Options $0.99 M 15571 Disposed 2021-06-17 Common Stock (15571) Direct

Footnotes

F1: right to buy.

F2: the option became exercisable in three equal installments ending on January 8, 2013.

F3: Since the date of the reporting person's last ownership report, he has transferred employee stock options to purchase an aggregate of 49,965 shares of ISR common stock to his ex-wife pursuant to a domestic relations order. The reporting person no longer reports as beneficially owned any securities by his ex-wife.

F4: the option becomes exercisable in three equal installments with two-thirds of the option shares exercisable as of June 30, 2013, and the remaining one-third will become exercisable on June 30, 2014.

F5: this amendment is required to be filed to correct an error on the original Form 4 filed on June 24, 2014. In the original Form 4 filing, footnote (2) was inadvertently added in the Section 3. Transaction Date columns in Table II for both entries, when it should have been added in Section 6., for the first entry only.